More News-mongering for Opexa Tovaxin Trial
Submitted by art on Tue, 2007-10-02 07:08.
In the multicenter, randomized, double blind, placebo-controlled TERMS study all 150 patients have received their first vaccine dose in the five dose vaccine series and more than 60% of the total 750 vaccine doses of the study have been delivered, the company said.
In addition, the company noted that the Data Safety Monitoring Board has met three times and reported no safety issues and recommends continuing the trial as planned.
Man, the PR firm for this trial is really earning its money. Every time someone sneezes near this trial they put out a press release.